Dietary agents in cancer prevention: flavonoids and isoflavonoids
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adlercreutz, 1990, Western diet and Western diseases: some hormonal and biochemical mechanisms and associations, Scand J Clin Lab Invest, 50, 3, 10.3109/00365519009085798
Adlercreutz, 1995, Phytoestrogens: epidemiology and a possible role in cancer protection, Environ Health Perspect, 103, 103, 10.2307/3432518
Alworth, 1985, Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyl-dibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice, Carcinogenesis, 6, 487, 10.1093/carcin/6.4.487
Anderson, 1999, Plant-based diets and bone health: nutritional implications, Am J Clin Nutr, 70, 539S, 10.1093/ajcn/70.3.539s
Appelbaum, 1992, The role of the immune system in the pathogenesis of cancer, Semin Oncol Nurs, 8, 51, 10.1016/0749-2081(92)90008-Q
Arora, 1998, Antioxidant activities of isoflavones and their biological metabolites in a liposomal system, Arch Biochem Biophys, 356, 133, 10.1006/abbi.1998.0783
Aziz, 2000, Absorption and excretion of conjugated flavonols, including quercetin-4′-O-ß-glucoside and isorhamnetin-4′-O-ß-glucoside by human volunteers after the consumption of onions, Free Radic Res, 29, 257, 10.1080/10715769800300291
Bennets, 1946, A specific breeding problem of sheep on subterranean clover pastures in western Australia, Aust Vet J, 22, 2, 10.1111/j.1751-0813.1946.tb15473.x
Benson, 1980, Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity, Proc Natl Acad Sci USA, 77, 5216, 10.1073/pnas.77.9.5216
Birt, 2001, Soybeans and cancer prevention: a complex food and a complex disease
Birt, 1986, Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol, Carcinogenesis, 7, 959, 10.1093/carcin/7.6.959
Birt, 1997, Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid, Anticancer Res, 17, 85
Birt, 1999, Chemoprevention of cancer, 1263
Block, 1992, Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence, Nutr Cancer, 18, 1, 10.1080/01635589209514201
Bohm, 1980, The minor flavonoids, 329
Booth, 1999, Isoflavones inhibits intestinal epithelial cell proliferation and induce apoptosis in vitro, Br J Cancer, 80, 1550, 10.1038/sj.bjc.6690559
Bravo, 1998, Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance, Nutr Rev, 56, 317, 10.1111/j.1753-4887.1998.tb01670.x
Brzezinski, 1997, Short-term effects of phytoestrogen-rich diet on postmenopausal women, Menopause, 4, 89, 10.1097/00042192-199704020-00005
Cai, 1997, Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals, Cancer Lett, 119, 99, 10.1016/S0304-3835(97)00261-9
Chang, 1985, Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9-10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse, Carcinogenesis, 6, 1127, 10.1093/carcin/6.8.1127
Chasseaud, 1979, The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents, Adv Cancer Res, 29, 175, 10.1016/S0065-230X(08)60848-9
Constantinou, 1990, Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein, Cancer Res, 50, 2618
Constantinou, 1994, Flavonoids as DNA topoisomerase antagonists and poisons: structure–activity relationships, Surg Oncol, 1, 2
Constantinou, 1996, Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones, Anticancer Res, 16, 3293
Constantinou, 1998, Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice, Am J Clin Nutr, 68, 1426S, 10.1093/ajcn/68.6.1426S
Czeczot, 1990, Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs, Mutat Res, 240, 209, 10.1016/0165-1218(90)90060-F
De Azevedo, 1996, Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase, Proc Natl Acad Sci USA, 93, 2735, 10.1073/pnas.93.7.2735
Deschner, 1991, Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia, Carcinogenesis, 12, 1193, 10.1093/carcin/12.7.1193
Deschner, 1993, The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet, Nutr Cancer, 20, 199, 10.1080/01635589309514287
Dewick, 1988, Isoflavonoids, 125
Elangovan, 1994, Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis, Cancer Lett, 87, 107, 10.1016/0304-3835(94)90416-2
End, 1987, Non-selective inhibition of mammalian protein kinases by flavinoids in vitro, Res Commun Chem Pathol Pharmacol, 56, 75
Farnsworth, 1975, Potential value of plants as sources of new antifertility agents II, J Pharm Sci, 64, 717, 10.1002/jps.2600640504
Foti, 1996, Flavonoids, coumarins, and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship, J Agric Food Chem, 44, 497, 10.1021/jf950378u
Fotsis, 1993, Genistein, a dietary-derived inhibitor of in vitro angiogenesis, Proc Natl Acad Sci USA, 90, 2690, 10.1073/pnas.90.7.2690
Fotsis, 1997, Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, 57, 2916
Fournier, 1998, Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data, Cancer Epidemiol Biomarkers Prev, 7, 1055
Frankel, 1993, Inhibition of oxidation of low-density lipoprotein by phenolic substances in red wine, Lancet, 341, 454, 10.1016/0140-6736(93)90206-V
Friedman, 1984, Factors which facilitate inactivation of quercetin mutagencity, Adv Exp Med Biol, 177, 527, 10.1007/978-1-4684-4790-3_24
Fritz, 1998, Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat, Carcinogenesis, 19, 2151, 10.1093/carcin/19.12.2151
Gamet-Payrastre, 1999, Flavonoids and the inhibition of PKC and PI 3-kinase, Gen Pharmacol, 32, 279, 10.1016/S0306-3623(98)00220-1
Garcia-Closas, 1998, Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer, 32, 154, 10.1080/01635589809514734
Giles, 1997, Effect of structurally related flavones/isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells, Nutr Cancer, 29, 77, 10.1080/01635589709514605
Gordon, 1991, Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes, Carcinogenesis, 12, 2393, 10.1093/carcin/12.12.2393
Graefe, 2000, Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from equisetum arvense, Phytomedicine, 6, 239, 10.1016/S0944-7113(99)80015-4
Griffiths, 1972, Metabolism of apigenin and related compounds in the rat; metabolite formation in vivo and by the intestinal microflora in vitro, Biochem J, 128, 901, 10.1042/bj1280901
Guthrie, 1998, Inhibition of mammary cancer by citrus flavonoids, Adv Exp Med Biol, 439, 227, 10.1007/978-1-4615-5335-9_16
Harborne, 1989, General procedures and measurement of total phenolics, Vol. 1, 1
Havlin, 1991, Phase I clinical and pharmacokinetic trial of flavone acetic acid, J Natl Cancer Inst, 83, 124, 10.1093/jnci/83.2.124
Heinonen, 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-tocopherol, Beta Carotene Cancer Prevention Study Group, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501
Hendrich, 1998, Isoflavones metabolism and bioavailability, 211
Hendrich, 1998, Human bioavailability of soy bean isoflavones: influences of diet, dose, time and gut microflora, 150
Hertog, 1992, Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands, J Agric Food Chem, 40, 2379, 10.1021/jf00024a011
Hertog, 1993, Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices, J Agric Food Chem, 41, 1242, 10.1021/jf00032a015
Hertog, 1994, Dietary flavonoids and cancer risk in the Zutphen elderly study, Nutr Cancer, 22, 175, 10.1080/01635589409514342
Hertog, 1995, Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study, Arch Intern Med, 155, 381, 10.1001/archinte.155.4.381
Heruth, 1995, Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel, J Cell Biochem, 58, 83, 10.1002/jcb.240580111
Hirano, 1994, Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells, Life Sci, 55, 1061, 10.1016/0024-3205(94)00641-5
Hollman, 1997, Absorption, metabolism and health effects of dietary flavonoids in man, Biomed Pharmacother, 51, 305, 10.1016/S0753-3322(97)88045-6
Hollman, 1998, Bioavailability and health effects of dietary flavonols in man, Arch Toxicol Suppl, 20, 237, 10.1007/978-3-642-46856-8_21
Hollman, 1995, Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers, Am J Clin Nutr, 62, 1276, 10.1093/ajcn/62.6.1276
Hollman, 1997, Bioavailability of the dietary antioxidant flavonol quercetin in man, Cancer Lett, 114, 139, 10.1016/S0304-3835(97)04644-2
Hollman, 1999, The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man, Free Radic Res, 31, 569, 10.1080/10715769900301141
Hosokawa, 1990, Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells, Int J Cancer, 45, 1119, 10.1002/ijc.2910450622
Hsieh, 1998, Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo, Cancer Res, 58, 3833
Hu, 1988, Diet and cancer of the stomach: a case-control study in China, Int J Cancer, 41, 331, 10.1002/ijc.2910410302
Hudson, 1983, Polyhydroxy flavonoid antioxidants for edible oils: structural criteria for activity, Food Chem, 10, 47, 10.1016/S0308-8146(83)80001-6
Hughes, 1999, Effects of dietary antioxidants on the immune function of middle-aged adults, Proc Nutr Soc, 58, 79, 10.1079/PNS19990012
Husain, 1987, Hydroxyl radical scavenging activity of flavonoids, Phytochemistry, 26, 2489, 10.1016/S0031-9422(00)83860-1
Hutchins, 1995, Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products, J Am Diet Assoc, 95, 545, 10.1016/S0002-8223(95)00149-2
Kal, 1992, Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid, In Vivo, 6, 73
Kanazawa, 1998, Antimutagenicity of flavones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family, Biosci Biotechnol Biochem, 62, 970, 10.1271/bbb.62.970
Kandaswami, 1991, Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro, Cancer Lett, 56, 147, 10.1016/0304-3835(91)90089-Z
Karr, 1997, Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption, Am J Clin Nutr, 66, 46, 10.1093/ajcn/66.1.46
Kawaii, 1999, Antiproliferative activity of flavonoids on several cancer cell lines, Biosci Biotechnol Biochem, 63, 896, 10.1271/bbb.63.896
Kawamori, 1995, Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats, Cancer Res, 55, 1277
Kelly, 1993, Metabolites of dietary (soya) isoflavones in human urine, Clin Chim Acta, 223, 9, 10.1016/0009-8981(93)90058-C
Kennedy, 1995, The evidence for soybean products as cancer preventive agents, J Nutr, 125, 733S
King, 1998, Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans, Am J Clin Nutr, 67, 867, 10.1093/ajcn/67.5.867
King, 1996, Absorption and excretion of the soy isoflavone genistein in rats, J Nutr, 126, 176, 10.1093/jn/126.1.176
Knekt, 1997, Dietary flavonoids and the risk of lung cancer and other malignant neoplasms, Am J Epidemiol, 146, 223, 10.1093/oxfordjournals.aje.a009257
Knight, 1996, A review of the clinical effects of phytoestrogens, Obstet Gynecol, 87, 897
Konoshima, 1992, Studies on inhibitors of skin tumor promotion. XI. Inhibitory effects of flavonoids from Scutellaria baicalensis on Epstein–Barr virus activation and their anti-tumor-promoting activities, Chem Pharm Bull (Tokyo), 40, 531, 10.1248/cpb.40.531
Koo, 1988, Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked, Nutr Cancer, 11, 155, 10.1080/01635588809513983
Kuo, 1995, Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes, Biochem Biophys Res Commun, 212, 767, 10.1006/bbrc.1995.2035
Kuo, 1994, Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine, Cancer Lett, 87, 91, 10.1016/0304-3835(94)90414-6
Kuo, 1996, Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells, Cancer Lett, 110, 41, 10.1016/S0304-3835(96)04458-8
Kuo, 1997, Dietary flavonoid and cancer prevention: evidence and potential mechanism, Crit Rev Oncog, 8, 47, 10.1615/CritRevOncog.v8.i1.30
Kyle, 1997, Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity, Mol Pharmacol, 51, 193, 10.1124/mol.51.2.193
Lahiri-Chatterjee, 1999, A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model, Cancer Res, 59, 622
Lamartiniere, 1995, Neonatal genistein chemoprevents mammary cancer, Proc Soc Exp Biol Med, 208, 120, 10.3181/00379727-208-43843
Lamartiniere, 1998, Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats, Proc Soc Exp Biol Med, 217, 358, 10.3181/00379727-217-44245
Lamartiniere, 1998, Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity, Am J Clin Nutr, 68, 1400S, 10.1093/ajcn/68.6.1400S
Lampe, 1998, Urinary equol excretion with a soy challenge: influence of habitual diet, Proc Soc Exp Biol Med, 217, 335, 10.3181/00379727-217-44241
Le Bail, 1998, Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids, Cancer Lett, 130, 209, 10.1016/S0304-3835(98)00141-4
Lee, 1995, Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver, Nutr Cancer, 24, 267, 10.1080/01635589509514416
Lee, 1995, Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids, Life Sci, 57, 551, 10.1016/0024-3205(95)00305-P
Lee, 1999, Inhibitory effect of munetone, an isoflavonoid, on 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity, Cancer Lett, 136, 59, 10.1016/S0304-3835(98)00309-7
Lepley, 1997, Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin, Mol Carcinog, 19, 74, 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L
Lepley, 1996, The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes, Carcinogenesis, 17, 2367, 10.1093/carcin/17.11.2367
Lewis, 1993, Plant phenolics, 135
Li, 1999, Soybean isoflavones reduce experimental metastasis in mice, J Nutr, 129, 1075, 10.1093/jn/129.5.1075
Lian, 1998, Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line, Nutr Cancer, 31, 184, 10.1080/01635589809514701
Lichtenstein, 1998, Soy protein, isoflavones and cardiovascular disease risk, J Nutr, 128, 1589, 10.1093/jn/128.10.1589
Lien, 1999, Quantitative structure–activity relationship analysis of phenolic antioxidants, Free Radic Biol Med, 26, 285, 10.1016/S0891-5849(98)00190-7
Lowell, 1990, Dietary immunomodulation: beneficial effects on oncogenesis and tumor growth, Crit Care Med, 18, s145, 10.1097/00003246-199002003-00010
Lu, 1995, Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects, Nutr Cancer, 24, 311, 10.1080/01635589509514420
Lu, 1997, Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure, Nutr Cancer, 26, 289, 10.1080/01635589609514485
Makela, 1995, Dietary soybean may be antiestrogenic in male mice, J Nutr, 125, 437
Makita, 1996, Chemoprevention of 4-nitraquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin, Cancer Res, 56, 4904
Markaverich, 1988, Methyl p-hydroxyphenyllactate — an inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites, J Biol Chem, 263, 7203, 10.1016/S0021-9258(18)68628-4
Matsukawa, 1993, Genistein arrests cell cycle progression at G2-M, Cancer Res, 53, 1328
Messina, 1998, The role of soy in preventing and treating chronic disease, Am J Clin Nutr, 68, 1329S, 10.1093/ajcn/68.6.1329S
Middleton, 1998, Effect of plant flavonoids on immune and inflammatory cell function, Adv Exp Med Biol, 439, 175, 10.1007/978-1-4615-5335-9_13
Middleton, 1992, Effects of flavonoids on immune and inflammatory cell functions, Biochem Pharmacol, 43, 1167, 10.1016/0006-2952(92)90489-6
Miksicek, 1993, Commonly occurring plant flavonoids have estrogenic activity, Mol Pharmacol, 44, 37
Miksicek, 1995, Estrogenic flavonoids: structural requirements for biological activity, Proc Soc Exp Biol Med, 201, 44, 10.3181/00379727-208-43830
Mitchell, 1998, Antioxidant efficacy of phytoestrogens in chemical and biological model systems, Arch Biochem Biophys, 360, 142, 10.1006/abbi.1998.0951
Mitsuoka, 1982, Recent trends in research on intestinal flora, Bifidobacteria Microflora, 3, 3, 10.12938/bifidus1982.1.1_3
Moule, 1963, The significance of oestrogens in pasture plants in relation to animal production, Anim Breeding Abstr, 31, 139
Naik, 1994, An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer, Anticancer Res, 14, 2617
Nijhoff, 1993, Induction of rat hepatic and intestinal glutathione S-transferases and glutathione by dietary naturally occurring anticarcinogens, Int J Oncol, 3, 1131
Nixon, 1984, Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds, Carcinogenesis, 5, 615, 10.1093/carcin/5.5.615
Noroozi, 1998, Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes, Am J Clin Nutr, 67, 1210, 10.1093/ajcn/67.6.1210
Omenn, 1995, What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart diseases, Ann Epidemiol, 5, 333, 10.1016/1047-2797(95)90014-4
Omenn, 1996, Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease, N Engl J Med, 334, 1150, 10.1056/NEJM199605023341802
Onozawa, 1999, Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats, Jpn J Cancer Res (Amsterdam), 90, 393, 10.1111/j.1349-7006.1999.tb00760.x
Pereira, 1994, Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents, Carcinogenesis, 15, 1049, 10.1093/carcin/15.5.1049
Peterson, 1998, Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines, Am J Clin Nutr, 68, 1505S, 10.1093/ajcn/68.6.1505S
Piantelli, 1993, Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas, Cancer, 71, 193, 10.1002/1097-0142(19930101)71:1<193::AID-CNCR2820710130>3.0.CO;2-C
Pierpoint, 1986, Flavonoids in the human diet, 125
Plaumann, 1996, Flavonoids activate wild-type p53, Oncogene, 13, 1605
Pollard, 1997, Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L–W rats, Nutr Cancer, 28, 41, 10.1080/01635589709514551
Potter, 1996, Vegetables, fruit and phytoestrogens as preventive agents, IARC Sci Publ, 139, 61
Ratty, 1988, Effects of flavonoids on nonenzymatic lipid peroxidation: structure–activity relationship, Biochem Med Metab Biol, 39, 69, 10.1016/0885-4505(88)90060-6
Renaud, 1992, Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet, 339, 1523, 10.1016/0140-6736(92)91277-F
Robak, 1988, Flavonoids are scavengers of superoxide anion, Biochem Pharmacol, 37, 83, 10.1016/0006-2952(88)90169-4
Rodgers, 1998, The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells, Chem Biol Interact, 116, 213, 10.1016/S0009-2797(98)00092-1
Setchell, 1984, Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease, Am J Clin Nutr, 40, 569, 10.1093/ajcn/40.3.569
Severson, 1989, A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii, Cancer Res, 49, 1857
Sfakianos, 1997, Intestinal uptake and biliary excretion of the isoflavone genistein in rats, J Nutr, 127, 1260, 10.1093/jn/127.7.1260
Shutt, 1972, Steroid and phyto-estrogen binding to sheep uterine receptors in vitro, J Endocrinol, 52, 299, 10.1677/joe.0.0520299
So, 1996, Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices, Nutr Cancer, 26, 167, 10.1080/01635589609514473
Sorensen, 1998, The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse, Cancer Lett, 130, 217, 10.1016/S0304-3835(98)00139-6
Spinozzi, 1994, The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jukat T-leukemia cells, Leuk Res, 18, 431, 10.1016/0145-2126(94)90079-5
Steinmetz, 1991, Vegetables, fruit, and cancer. I. Epidemiology, Cancer Causes Control, 2, 325, 10.1007/BF00051672
Steinmetz, 1991, Vegetables, fruit, and cancer. II. Mechanisms, Cancer Causes Control, 2, 427, 10.1007/BF00054304
Steinmetz, 1994, Vegetables, fruit, and colon cancer in the Iowa women's health study, Am J Epidemiol, 139, 1, 10.1093/oxfordjournals.aje.a116921
Talalay, 1989, Mechanisms of induction of enzymes that protect against chemical carcinogenesis, Adv Enzyme Regul, 28, 237, 10.1016/0065-2571(89)90074-5
Talalay, 1995, Chemoprotection against cancer by phase 2 enzyme induction, Toxicol Lett, 82–83, 173, 10.1016/0378-4274(95)03553-2
Tanaka, 1997, Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin, Carcinogenesis, 18, 957, 10.1093/carcin/18.5.957
Tanaka, 1997, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination, Cancer Res, 57, 246
Tew, 1996, A diet high in wheat fiber suppresses the bioavailability of isoflavones in a single meal fed to women, J Nutr, 126, 871, 10.1093/jn/126.4.871
Thiagarajan, 1998, Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium, Am J Clin Nutr, 68, 1394S, 10.1093/ajcn/68.6.1394S
Torel, 1986, Antioxidant activity of flavonoids and reactivity with peroxy radical, Phytochemistry, 25, 383, 10.1016/S0031-9422(00)85485-0
Traganos, 1992, Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells, Cancer Res, 52, 6200
Verdeal, 1979, Naturally-occurring estrogens in plant foodstuffs — a review, J Food Prot, 42, 577, 10.4315/0362-028X-42.7.577
Waladkhani, 1998, Effect of dietary phytochemicals on cancer development, Int J Med, 1, 747
Wang, G.-J. (1997). Human gut microfloral metabolism of soybean isoflavones. Master's Thesis, Iowa State University.
Wang, 1994, Isoflavone content of commercial soybean foods, J Agric Food Chem, 42, 1666, 10.1021/jf00044a016
Wang, 1999, Antioxidant property of dietary phenolic agents in a human LDL-oxidation ex vivo model: interaction of protein binding activity, Nutr Res, 19, 191, 10.1016/S0271-5317(98)00183-3
Wang, 1995, Induction of NAD(P)H:quinone reductase by vitamins A, E and C in Colo205 colon cancer cells, Cancer Lett, 98, 63
Wang, 2000, Dietary soy protein is associated with reduced intestinal mucosal polyamine concentration in male Wistar rats, J Nutr, 130, 1815, 10.1093/jn/130.7.1815
Wang, 1995, Proliferative response of mammary glandular tissues to formononetin, Nutr Cancer, 23, 131, 10.1080/01635589509514369
Wang, 1997, Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation, Nutr Cancer, 29, 29, 10.1080/01635589709514598
Wang, 1998, Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells, Biochem Pharmacol, 56, 189, 10.1016/S0006-2952(98)00141-5
Wang, 2000, Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines, Mol Carcinog, 28, 102, 10.1002/1098-2744(200006)28:2<102::AID-MC6>3.0.CO;2-2
Watanabe, 1998, Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after injestion of 60 g baked soybean powder (Kinako), J Nutr, 128, 1710, 10.1093/jn/128.10.1710
Watson, 1986, Immunological enhancement by fat-soluble vitamins, minerals, and trace metals: a factor in cancer prevention, Cancer Detect Prev, 9, 67
Wattenberg, 1992, Inhibition of carcinogenesis by minor dietary constituents, Cancer Res, 52, 2085s
Wattenberg, 1992, Chemoprevention of cancer by naturally occurring and synthetic compounds, 19
Wei, 1990, Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice, Cancer Res, 50, 499
Wei, 1998, Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice, Carcinogenesis, 19, 1509, 10.1093/carcin/19.8.1509
Wei, 1994, Induction of apoptosis by quercetin: involvemnt of heat shock protein, Cancer Res, 54, 4952
Wei, 1994, Induction of apoptosis by quercetin: involvement of heat shock protein, Cancer Res, 54, 4952
Winter, 1989, C-ring cleavage of flavonoids by human intestinal bacteria, Appl Environ Microbiol, 55, 1203, 10.1128/AEM.55.5.1203-1208.1989
Wiseman, 1999, The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-estrogens, Proc Nutr Soc, 58, 139, 10.1079/PNS19990019
Wu, 1998, Soy intake and risk of breast cancer in Asians and Asian Americans, Am J Clin Nutr, 68, 1437S, 10.1093/ajcn/68.6.1437S
Xu, 1994, Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women, J Nutr, 124, 825, 10.1093/jn/124.6.825
Xu, 1995, Bioavailability of soybean isoflavones depends upon gut microflora in women, J Nutr, 125, 2307, 10.1093/jn/125.9.2307
Xu, 2000, Neither background diet choice nor type or soy food affect isoflavone bioavailability in women, J Nutr, 130, 798, 10.1093/jn/130.4.798
Yamanaka, 1997, Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu(2+)-induced low density lipoprotein oxidation, FEBS Lett, 405, 186, 10.1016/S0014-5793(97)00185-3
Yoshida, 1992, Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle, Cancer Res, 52, 6676
Zhang, 1997, Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats, Cancer Lett, 114, 313, 10.1016/S0304-3835(97)04690-9
Zhang, 1997, Enhancement of immune function in mice fed high doses of soy daidzein, Nutr Cancer, 29, 24, 10.1080/01635589709514597
Zhang, 1999, Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells in nutritionally relevant concentrations, J Nutr, 129, 399, 10.1093/jn/129.2.399
Zhang, 1999, Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity, J Nutr, 129, 957, 10.1093/jn/129.5.957
Zheng, 1999, Urinary excretion of isoflavonoids and the risk of breast cancer, Cancer Epidemiol Biomarkers Prev, 8, 35
Zheng, Y. (2000). Ethnicity and diet habits: influence on isoflavone bioavailability in women. Master's Thesis, Iowa State University.
Zhou, 1998, Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis, Cancer Res, 58, 5231
Zi, 1998, A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells, Cancer Res, 58, 1920